Defining a cohort of men who may not require repeat prostate biopsy based on PCA3 score and MRI: The dual negative effect.
J Urol. 2017 Nov 23;:
Eur Urol. 2017 Nov 06;:
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicion.
Urol Oncol. 2017 Aug 03;:
Testosterone Responders to Continuous Androgen Deprivation Therapy Exhibit Considerable Variations in Testosterone Levels on Follow-Up: Implications for Clinical Practice.
J Urol. 2017 Jul 24;:
What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?
Can Urol Assoc J. 2017 Mar-Apr;11(3-4):118-122
Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohort.
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):41-46
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
J Clin Oncol. 2017 Apr 14;:JCO2016692327
J Natl Cancer Inst. 2017 Apr 01;109(4):
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.
Transl Oncol. 2017 Feb 03;10(2):168-177
The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy.
Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E424-E427